IP Library Granted Patent US 8,022,204
Granted Patent B2
US 8,022,204 · App. 12/316,115 · Granted Sep 20, 2011

Process of making 3-phenylimino-3H-phenothiazine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,022,204
App. No.
12/316,115
Granted
Sep 20, 2011
Kind
B2
Abstract

A method of forming a 3-phenylimino-3H-phenothiazine or a 3-phenylimino-3H-phenoxazine mediator includes providing a first reactant including phenothiazine or phenoxazine, providing a first solvent, providing a second reactant and providing a second solvent. The first reactant, first solvent, second reactant and second solvent are combined to form a reactants solution. Sodium persulfate is added to the reactants solution to couple the first and second reactants resulting in a reaction solution including the 3-phenylimino-3H-phenothiazine or the 3-phenylimino-3H-phenoxazine mediator.

Claims (33)

1. A method of forming a 3-phenylimino-3H-phenothiazine mediator, the method comprising the acts of:

providing a first reactant including phenothiazine;

providing a first solvent in which the phenothiazine has a desired solubility therein;

providing a second reactant to assist in forming the 3-phenylimino-3H-phenothiazine mediator;

providing a second solvent in which the second reactant has a desired solubility therein;

combining the first reactant, first solvent, second reactant and second solvent to form a reactants solution;

adding sodium persulfate to the reactants solution to couple the first and second reactants resulting in a reaction solution including the 3-phenylimino-3H-phenothiazine mediator; and

after adding the sodium persulfate, further processing to the reaction solution including the 3-phenylimino-3H-phenothiazine mediator so as to isolate the 3-phenylimino-3H-phenothiazine mediator.

2. The method of claim 1 , wherein the first solvent includes tetrahydrofuran (THF).

3. The method of claim 1 , wherein the second solvent includes water.

4. The method of claim 3 , wherein the second solvent further includes sodium hydroxide.

5. The method of claim 1 wherein combining the first reactant, first solvent, second reactant and second solvent including the acts of combining the first reactant and the first solvent to form a first reactant solution, and combining the second reactant and the second solvent to form a second reactant solution before the first reactant, first solvent, second reactant and second solvent are combined together to form the reactants solution.

6. The method of claim 1 , wherein further processing includes generally removing the second solvent by adding acetronitrile.

7. The method of claim 1 , wherein further processing includes generally removing the first solvent by adding ethyl acetate.

8. The method of claim 1 , wherein the second reactant includes aniline 2,5-disulfonic acid.

9. The method of claim 1 , wherein the further processing includes substantially removing at least the first solvent and second solvent from the second solution so as to isolate the 3-phenylimino-3H-phenothiazine mediator.

10. The method of claim 1 , wherein the 3-phenylimino-3H-phenothiazine mediator is in the form of a salt.

11. A method of forming and stabilizing a 3-phenylimino-3H-phenothiazine mediator, the method comprising the acts of:

providing a first reactant including phenothiazine;

providing a first solvent in which the phenothiazine has a desired solubility therein;

providing a second reactant to assist in forming the 3-phenylimino-3H-phenothiazine mediator;

providing a second solvent in which the second reactant has a desired solubility therein;

combining the first reactant, first solvent, second reactant and second solvent to form a reactants solution;

adding a coupling agent to the reactants solution to couple the first and second reactants resulting in a reaction solution including the 3-phenylimino-3H-phenothiazine mediator; and

after adding the coupling agent, further processing to the reaction solution including the 3-phenylimino-3H-phenothiazine mediator so as to isolate the 3-phenylimino-3H-phenothiazine mediator; and

stabilizing the 3-phenylimino-3H-phenothiazine mediator to a pH of from about 5 to about 8.

12. The method of claim 11 , wherein the pH is from about 5.5 to about 7.

13. The method of claim 12 , wherein the pH is from about 6 to about 7.

14. The method of claim 12 , wherein the stabilizing the 3-phenylimino-3H-phenothiazine mediator includes adding sodium hydroxide, sodium bicarbonate, sodium phosphate, tetrabutylammonium hydroxide, calcium hydroxide, potassium hydroxide, potassium phosphate, potassium bicarbonate or combinations thereof.

15. The method of claim 11 , wherein the first solvent includes tetrahydrofuran (THF).

16. The method of claim 11 , wherein the second solvent includes water.

17. The method of claim 16 , wherein the second solvent further includes sodium hydroxide.

18. The method of claim 11 , wherein the second reactant includes aniline 2,5-disulfonic acid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE STATE NAME PREVIOUSLY RECORDED AT REEL: 022026 FRAME: 0354. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 22, 2015
From: MARFURT, KAREN L.; ARNDT, HENRY C.
To: BAYER HEALTHCARE LLC
Reel/Frame 037359/0221 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2008
From: MARFURT, KAREN L.; ARNDT, HENRY C.
To: BAYER HEALTHCARE LLC
Reel/Frame 022026/0354 →